Hemab Therapeutics Holdings, Inc. Common Stock COAG
$31.62
+2.36%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-09-25 | View → |
| 8-K | 8-K | 2026-09-24 | View → |
| 10-Q | 10-Q | 2026-08-11 | View → |
| 8-K | 8-K | 2026-08-11 | View → |
| 4 | Insider transaction | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 10-Q | 10-Q | 2026-05-21 | View → |
| 8-K | 8-K | 2026-05-21 | View → |
| 4 | Insider transaction | 2026-05-14 | View → |
| 4 | Insider transaction | 2026-05-11 | View → |
| 8-K | 8-K | 2026-05-11 | View → |
| 4 | Insider transaction | 2026-05-06 | View → |
| 4 | Insider transaction | 2026-05-06 | View → |
| 4 | 4 | 2026-05-04 | View → |
| 4 | 4 | 2026-05-04 | View → |
| 4 | 4 | 2026-05-04 | View → |
| 8-K | 8-K | 2026-05-04 | View → |
| S-1 | S-1 | 2026-04-10 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $31.62
- Market Cap
- $1.44 billion
- 52-Week Range
- $23.00 – $55.42
- Average Volume
- 552K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.